NOVN.CH

97.3

-0.74%↓

LONN.CH

548.2

+0.22%↑

BANB.CH

63.2

+1.77%↑

NOVN.CH

97.3

-0.74%↓

LONN.CH

548.2

+0.22%↑

BANB.CH

63.2

+1.77%↑

NOVN.CH

97.3

-0.74%↓

LONN.CH

548.2

+0.22%↑

BANB.CH

63.2

+1.77%↑

NOVN.CH

97.3

-0.74%↓

LONN.CH

548.2

+0.22%↑

BANB.CH

63.2

+1.77%↑

NOVN.CH

97.3

-0.74%↓

LONN.CH

548.2

+0.22%↑

BANB.CH

63.2

+1.77%↑

Inicio・Lista de Acciones・Roche Holding AG

Roche Holding AG

Abierto

SectorSalud

274.6 -0.72

Comprar Vender

Resumen

Variación precio

24h

Actual

Mínimo

268.4

Máximo

278

Métricas clave
By Trading Economics
Ingresos	5.8B 7.8B
Ventas	297M 31B
P/B Media del Sector	24.272 35.664
Rentabilidad por dividendo	3.4
Margen de beneficio	25.31
Empleados	103,249
EBITDA	6B

Dividendos
By Dow Jones
Rentabilidad por dividendo Media del Sector	3.40% 3.12%

Estadísticas de Mercado
By TradingEconomics
Capitalización de Mercado	11B 217B
Apertura anterior	275.32
Cierre anterior	274.6

Noticias sobre sentimiento de mercado

By Acuity

32%

68%

106 / 371 Clasificación en Healthcare

Roche Holding AG Gráfico

El rendimiento pasado no es un indicador fiable de resultados futuros.

Noticias Relacionadas

24 jul 2025, 15:09 UTC

Ganancias

Roche Weighs Selling Drugs Directly to Patients in Bid to Lower U.S. Prices -- Update

24 jul 2025, 05:36 UTC

Ganancias

Roche Backs 2025 Views After Strong Sales of Key Drugs

11 jun 2025, 08:25 UTC

Adquisiciones, fusiones, absorciones

EQT, Sanofi Co-Led $135 Million Funding Round for Spanish Biotech Company SpliceBio

12 may 2025, 02:16 UTC

Principales Movimientos del Mercado

Asia Pharma Stocks Fall After Trump's Plan to Cut Drug Costs

24 abr 2025, 07:30 UTC

Ganancias

Roche Sales Gain on Boost From Key Drugs Amid U.S. Production Push -- Update

24 abr 2025, 05:31 UTC

Ganancias

Roche Sales Rise Boosted By Key Drugs

8 ago 2025, 10:51 UTC

Charlas de Mercado

Adquisiciones, fusiones, absorciones

Novartis's Midterm Prospects Look Better Than Roche's -- Market Talk

8 ago 2025, 07:39 UTC

Charlas de Mercado

Ganancias

Roche Could Reach Peak Earnings Growth This Year -- Market Talk

5 ago 2025, 10:40 UTC

Charlas de Mercado

Roche, Novartis Face Limited Tariff Headwinds for Now -- Market Talk

24 jul 2025, 06:52 UTC

Charlas de Mercado

Ganancias

Roche Looks Confident in a Tricky Environment -- Market Talk

24 jul 2025, 05:05 UTC

Ganancias

Roche Backs 2025 View

24 jul 2025, 05:05 UTC

Ganancias

Correct: Roche 1H Diagnostics Sales Down 3%, Reported

24 jul 2025, 05:04 UTC

Ganancias

Correct: Roche 1H Sales Rose 4% On Year , Reported

24 jul 2025, 05:04 UTC

Ganancias

Roche 1H Net Pft Was Seen at CHF8.4B

24 jul 2025, 05:04 UTC

Ganancias

Roche 1H Net Pft CHF7.8B

24 jul 2025, 05:03 UTC

Ganancias

Roche 1H Oper Pft CHF12.0B

24 jul 2025, 05:03 UTC

Ganancias

Roche 1H Diagnostics Sales Down 3% at Constant Currency

24 jul 2025, 05:03 UTC

Ganancias

Roche 1H Sales Rose 4% On Year at Constant Currency

24 jul 2025, 05:02 UTC

Ganancias

Roche 1H Sales CHF30.9B , In Line With Analyst Views

21 jul 2025, 06:44 UTC

Charlas de Mercado

Roche Drug Candidate Disappoints in Lung Disease Trials -- Market Talk

16 jun 2025, 08:55 UTC

Acciones populares

Stocks to Watch: Victoria's Secret, Renault, U.S. Steel, Sarepta -- WSJ

3 jun 2025, 07:51 UTC

Charlas de Mercado

Roche Unlikely to Get Revenue Boost From Tecentriq Combination With Lurbinectedin -- Market Talk

21 may 2025, 07:20 UTC

Charlas de Mercado

Roche Lymphoma Drug Columvi Dealt Setback by FDA Committee -- Market Talk

2 may 2025, 06:25 UTC

Charlas de Mercado

Ganancias

Roche Shows Pipeline Progress But Near-Term Risks Remain -- Market Talk

24 abr 2025, 09:39 UTC

Charlas de Mercado

Ganancias

Roche's Pipeline in Focus After Solid Results -- Market Talk

24 abr 2025, 09:24 UTC

Charlas de Mercado

Ganancias

Roche's Reiterated Outlook Looks Reassuring -- Market Talk

24 abr 2025, 09:18 UTC

Charlas de Mercado

Ganancias

Roche's Results Are Solid -- Market Talk

24 abr 2025, 05:16 UTC

Principales Noticias

Roche Sales Rise, Boosted By Key Drugs

22 abr 2025, 10:51 UTC

Principales Noticias

Drug Companies Step Up 'Make in America' Plans to Counter Tariffs -- WSJ

15 abr 2025, 09:55 UTC

Charlas de Mercado

U.S Pharma Import Probe Clouds Clarity for EU Companies -- Market Talk

Comparación entre iguales

Cambio de precio

Roche Holding AG Esperado

Sentimiento

By Acuity

106 / 371 Clasificación en Salud

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

Acerca de Roche Holding AG

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and Oceania. The company offers pharmaceutical products in the therapeutic areas of anemia, blood and solid tumors, dermatology, hemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation. It is also developing products for various therapeutic areas. In addition, it offers in vitro tests for the diagnosis of various diseases, such as cancer, diabetes, Covid-19, hepatitis, human papillomavirus, and other diseases; diagnostic instruments; and digital health solutions. It has strategic discovery collaboration with Flare Therapeutics Inc. proteomic and mass spectrometry platform and expertise to discover novel small molecules aimed at transcription factor targets in oncology. Roche Holding AG was founded in 1896 and is based in Basel, Switzerland.